FDA Approves Accelerated 7-Day Vaccine Dosing Schedule for Ixiaro

GAITHERSBURG, Md.--(BUSINESS WIRE) October 05, 2018 --Valneva USA, the U.S. subsidiary of global vaccine biotech company Valneva SE, today announced U.S. Food and Drug Administration (FDA) approval of an accelerated dosing regimen for Ixiaro...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news